Improvement of Biodistribution with PEGylated Liposomes Containing Docetaxel with Degradable Starch Microspheres for Hepatic Arterial Infusion in the Treatment of Liver Metastases: A Study in CC-531 Liver Tumor-bearing WAG RIJ RatsPOHLEN, U; BUHR, H. J; BERGER, G et al.Anticancer research. 2011, Vol 31, Num 1, pp 153-159, issn 0250-7005, 7 p.Article

Multicenter pilot study of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres via hepatic arterial infusion in patients with nonresectable colorectal liver metastasesPOHLEN, U; MANSMANN, U; BERGER, G et al.Anticancer research. 2004, Vol 24, Num 5B, pp 3275-3282, issn 0250-7005, 8 p.Article

Intra-aortal therapy with 5-fluorouracil-polyethylene glycol stealth liposomes : Does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on pH value? An animal study in VX-2 liver tumor-bearing rabbitsPOHLEN, U; BINNENHEI, M; RESZKA, R et al.Chemotherapy (Basel). 2004, Vol 50, Num 2, pp 67-75, issn 0009-3157, 9 p.Article

Increased carboplatin concentration in liver tumors through temporary flow retardation with starch microspheres (Spherex) and gelatin powder (Gelfoam) : An experimental study in liver tumor-bearing rabbitsPOHLEN, U; BERGER, G; BINNENHEI, M et al.The Journal of surgical research. 2000, Vol 92, Num 2, pp 165-170, issn 0022-4804Article

Hepatic Arterial Infusion in the Treatment of Liver Metastases with PEG Liposomes in Combination with Degradable Starch Microspheres (DSM) Increases Tumor 5-FU Concentration. An Animal Study in CC-531 Liver Tumor-bearing RatsPOHLEN, U; RESZKA, R; BUHR, H. J et al.Anticancer research. 2011, Vol 31, Num 1, pp 147-152, issn 0250-7005, 6 p.Article

Diagnostics and surgical treatment strategy for rectal cavernous hemangiomas based on three case examplesPOHLEN, U; KROESEN, A. J; BERGER, G et al.International journal of colorectal disease (Print). 1999, Vol 14, Num 6, pp 300-303, issn 0179-1958Article

Phase II study of regional chemotherapy using the hypoxic abdominal perfusion technique in advanced abdominal carcinoma. 5-FU pharmacokinetics, complications and outcomePOHLEN, U; RIEGER, H; KUNICK-POHLEN, S et al.Anticancer research. 2007, Vol 27, Num 1B, pp 667-674, issn 0250-7005, 8 p.Article

Hepatic arterial infusion (HAI). Comparison of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres versus 5-fluorouracil and folinic acid in patients with non-resectable colorectal liver metastasesPOHLEN, U; RIEGER, H; MANSMANN, U et al.Anticancer research. 2006, Vol 26, Num 5B, pp 3957-3964, issn 0250-7005, 8 p.Article

Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring : An experimental study on the VX2 tumor in the rabbit liverPÄUSER, S; WAGNER, S; LIPPMANN, M et al.Cancer research (Baltimore). 1996, Vol 56, Num 8, pp 1863-1867, issn 0008-5472Article

Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 Liver tumor-bearing rabbitsPOHLEN, U; RESZKA, R; SCHNEIDER, P et al.Anticancer research. 2004, Vol 24, Num 3A, pp 1699-1704, issn 0250-7005, 6 p.Article

Temporary unilateral microembolization of the lung: A new approach to regional chemotherapy for pulmonary metastasesSCHNEIDER, P; FOITZIK, T; POHLEN, U et al.The Journal of surgical research. 2002, Vol 107, Num 2, pp 159-166, issn 0022-4804, 8 p.Article

Simultaneous determination of 5-fluorouracil and its active metabolites in serum and tissue by high-performance liquid chromatographyJUNG, M; BERGER, G; POHLEN, U et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 702, Num 1-2, pp 193-202, issn 1387-2273Article